Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
1280
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Frontiers in medicine.
2022
February
16;
9
:761655
Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol
Arvind Chopra (1)
,
Arvind Chopra (1)
,
Manjit Saluja (1)
,
Manjit Saluja (1)
,
Sanjeev Sarmukaddam (2)
,
Sanjeev Sarmukaddam (2)
,
Preeti Chavan-Gautam (3)
,
Preeti Chavan-Gautam (3)
,
Girish Tillu (3)
,
Girish Tillu (3)
,
Swapnil Borse (3)
,
Swapnil Borse (3)
,
Bhushan Patwardhan (4)
,
Bhushan Patwardhan (4)
,
Susmita Chaudhuri (5)
,
Susmita Chaudhuri (5)
,
Bcs Rao (6)
,
Bcs Rao (6)
,
Babita Yadav (6)
,
Babita Yadav (6)
1. Center for Rheumatic Diseases, Pune, India 2. Center for Rheumatic Diseases, Pune, India 3. Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India 4. Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India 5. Translational Health Science and Technology Institute (THSTI), Faridabad, India 6. Central Council for Research in Ayurvedic Science, New Delhi, India.
Abstract
Introduction: Vaccines have emerged as the most effective tool in the fight against COVID-19. Governments all over the world have rolled out the COVID-19 vaccine program for their populations. Oxford-AstraZeneca COVID-19 vaccine (COVISHIELD™) is widely used in India. A large number of Indian people have been consuming various traditional medicines in the hope of better protection against COVID-19 infection. Several studies have reported immunological benefits of Withania somnifera (Ashwagandha) and its potential as a vaccine adjuvant. We propose to study the safety, immunogenicity and clinical protection offered by a 6-month regimen of Ashwagandha in participants who volunteer to be vaccinated against COVID-19 (COVISHIELDTM) in the ongoing national program of vaccination. Methods and analysis: We designed a prospective, randomized, double-blind, parallel-group, placebo-controlled, two-arm, exploratory study on healthy volunteers receiving the COVISHIELDTM vaccine. The administration of Ashwagandha will begin within 7 days of the first or second dose of COVISHIELDTM. Primary outcome measure is immunogenicity as measured by SARS-CoV-2 spike (S1) and RBD-specific IgG antibody titres. Secondary outcome measures are safety, protective immune response and quality of life measures. All adverse events will be monitored at each time throughout the study. Participants will be tracked on a daily basis with a user-friendly mobile phone application. Following power calculation 600 participants will be recruited per arm to demonstrate superiority by a margin of 7% with 80% power. Study duration is 28 weeks with interim analysis at the end of 12 weeks. Ethics and dissemination: Ethics approval was obtained through the Central and Institutional Ethics Committees. Participant recruitment commenced in December 2021. Results will be presented in conferences and published in preprints followed by peer-reviewed medical journals. Clinical trial registration: [www.ClinicalTrials.gov], identifier [CTRI/2021/06/034496]. Keywords: Ashwagandha; Ayurveda; COVID-19; Withania somnifera; immunoadjuvant; immunogenicity; vaccine. Copyright © 2022 Chopra, Chavan-Gautam, Tillu, Saluja, Borse, Sarmukaddam, Chaudhuri, Rao, Yadav, Srikanth and Patwardhan.
DHARA ID:
D058265
Pubmed ID:
35252231
Link To Full Paper
Replica Louis vuitton Belts
Replica Louis vuitton Handbags
Replica Louis vuitton Backpack
Replica Louis vuitton Capucines Bags
Imitazioni Louis vuitton Borse
Imitazioni Louis vuitton Cinture
Imitazioni Louis vuitton Occhiali
Replica Louis vuitton Geldb?rsen
Replica Louis vuitton Gürtel
Replica Louis vuitton Schmuck
Replica Louis vuitton Schal
Imitation Louis vuitton Bijoux
Imitation Louis vuitton Ceinture
Imitation Louis vuitton Chaussures
Imitation Louis vuitton Foulard
namaak Louis vuitton Gordels
namaak Louis vuitton Handtassen
namaak Louis vuitton Portemonnees
namaak Louis vuitton Schoenen
Replica Louis vuitton Bolsos
Replica Louis vuitton Billeteras
Replica Louis vuitton Cinturones
Dior Replica
Hermès Replica
Yves Saint Laurent Replica
Goyard Replica
Imitation Louis Vuitton
Imitation Hermès
Imitation Dior
Imitation Yves Saint Laurent
Imitazioni Bottega Veneta Borse
Imitazioni Delvaux Borse
Imitazioni Goyard Borse
Replica Taschen
Replica Louis Vuitton
Replica Hermès
Replica Dior
Replica Bottega Veneta tassen
Replica Chloé tassen
Replica Delvaux tassen
Replica Goyard tassen
imitacion Louis Vuitton
imitacion Louis Vuitton
imitacion Hermès
imitacion Dior
Replica Miu Miu
Replica Prada
Replica Yves Saint Laurent
Replica Chanel
Replica Gucci
Replica Hermès
Replica Miu Miu
Réplique Chanel
Réplique Hermès
Réplique Miu Miu
Imitazioni Chanel
Imitazioni Hermès
Imitazioni Miu Miu
imitacion Bolso Yves Saint Laurent
imitacion Hermes
imitacion Chanel
imitacion Gucci
Gucci Replica
Hermes Replica
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi